A Study to Assess Resistance and Durability of Response to ABT-493 and/or ABT-530
Public ClinicalTrials.gov record NCT02441283. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Follow-up Study to Assess Resistance and Durability of Response to AbbVie Direct-Acting Antiviral Agent (DAA) Therapy (ABT-493 and/or ABT-530) in Subjects Who Participated in Phase 2 or 3 Clinical Studies for the Treatment of Chronic Hepatitis C Virus (HCV) Infection
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This was a long-term follow-up study to evaluate the durability of sustained virologic response (SVR), persistence of direct-acting antiviral agent (DAA) resistance, and clinical outcomes for participants who received glecaprevir (ABT-493) and/or pibrentasvir (ABT-530) in prior AbbVie Phase 2 or 3 clinical studies for the treatment of chronic hepatitis C virus (HCV) infection.
Study identification
- NCT ID
- NCT02441283
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 384 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 22, 2015 (Actual)
- Primary completion
- Oct 15, 2019 (Actual)
- Completion
- Oct 15, 2019 (Actual)
- Last update posted
- Sep 21, 2020
2015 – 2019
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Digestive Health Specialists of the Southeast /ID# 136725 | Dothan | Alabama | 36305 | — |
| Felizarta /ID# 141033 | Bakersfield | California | 93301 | — |
| Southern California Res. Ctr. /ID# 141799 | Coronado | California | 92118-1408 | — |
| Research & Education, Inc. /ID# 169591 | San Diego | California | 92105 | — |
| eStudySite San Diego /ID# 141040 | San Diego | California | 92120 | — |
| eStudySite San Diego /ID# 141047 | San Diego | California | 92120 | — |
| eStudySite San Diego /ID# 141048 | San Diego | California | 92120 | — |
| Midway Immunology and Research /ID# 169477 | Ft. Pierce | Florida | 34982 | — |
| Delta Research Partners /ID# 141028 | Bastrop | Louisiana | 71220 | — |
| Louisiana Research Ctr. LLC /ID# 141024 | Shreveport | Louisiana | 71105-6800 | — |
| Henry Ford Health System /ID# 141039 | Detroit | Michigan | 48202 | — |
| Binghamton Gastroenterology /ID# 141026 | Binghamton | New York | 13903 | — |
| Carolinas Center for Liver Dis /ID# 155390 | Statesville | North Carolina | 28677-3471 | — |
| Northwest Gastroenterology Cli /ID# 141036 | Portland | Oregon | 97210 | — |
| Gastro One /ID# 169478 | Germantown | Tennessee | 38138 | — |
| Quality Medical Research, PLLC /ID# 141042 | Nashville | Tennessee | 37211 | — |
| TX Clinical Research Institute /ID# 141037 | Arlington | Texas | 76012 | — |
| Inquest Clinical Research /ID# 141045 | Baytown | Texas | 77521-2415 | — |
| TX Liver Inst, Americ Res Corp /ID# 136727 | San Antonio | Texas | 78215 | — |
| Bon Secours St. Mary's Hospita /ID# 165106 | Richmond | Virginia | 23226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02441283, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 21, 2020 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02441283 live on ClinicalTrials.gov.